A vaccine to protect babies from RSV is almost here, but children who need it may have trouble getting it
After more than five decades of attempts, the pharmaceutical industry is on the brink of providing effective immunizations against respiratory syncytial virus, which has put an estimated 90,000 American babies and young children in the hospital since the beginning of October.But only one of the vaccines is designed for babies, and a flaw in congressional language may make it difficult for children in low-income families to receive it as easily as those with good insurance.Since 1994, routine vaccination has been a right of childhood under the Vaccines for Children program, through which the federal government buys millions of vaccines and…
